Which companies overlap with Shanghai Eye Disease Prevention and Treatment Center's portfolio?

Top competitors by shared drug class: LitePharmTech Co., Ltd., Massachusetts Eye and Ear Infirmary, Oupushifang Pharmaceutical Technology Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/shanghai-eye-disease-prevention-and-treatment-center.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Shanghai Eye Disease Prevention and Treatment Center — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shanghai Eye Disease Prevention and Treatment Center pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Atropine Sulfate 0.01% Eye Drop	Atropine Sulfate 0.01% Eye Drop	marketed
Atropine Sulfate 0.04% Eye Drop	Atropine Sulfate 0.04% Eye Drop	marketed	Anticholinergic agent / Muscarinic receptor antagonist	Muscarinic acetylcholine receptors (M1, M3, M5)	Ophthalmology

Therapeutic area mix

Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

LitePharmTech Co., Ltd. · 1 shared drug class
Massachusetts Eye and Ear Infirmary · 1 shared drug class
Oupushifang Pharmaceutical Technology Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Shanghai Eye Disease Prevention and Treatment Center:

Cite this brief

Drug Landscape (2026). Shanghai Eye Disease Prevention and Treatment Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shanghai-eye-disease-prevention-and-treatment-center. Accessed 2026-05-18.